Femasys FEMY
NASDAQ FEMY
$2.83 +0.15 (+5.60%)
At close: Sep 9, 2026 · 4:00 PM EDT

Femasys (FEMY) Common Equity (2020 - 2026)

Femasys' (FEMY) quarterly Common Equity came in at $4.0 million in Q2 2026, up 167.4% on a YoY basis from $1.5 million in Q2 2025, and down 44.7% quarter-over-quarter from $7.3 million in Q1 2026.

Analysis

Femasys (FEMY) Common Equity (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Common Equity for 7 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Common Equity rose 167.4% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2026 stood at $4.0 million (up 167.4% YoY), and the FY2025 full-year result was $5.9 million, up 154.7% from the prior year.
  • Common Equity retreated to $4.0 million in Q2 2026 per FEMY's latest filing, from $7.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $23.5 million in Q1 2022 and bottomed at $1.5 million in Q2 2025.
  • Historically, Common Equity has averaged $10.7 million across 5 years, with a median of $10.8 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Common Equity sank 87.44% in 2024, then surged 265.09% in 2026.
  • Over 5 years, Common Equity stood at $15.2 million in 2022, then grew by 20.4% to $18.4 million in 2023, then tumbled by 87.44% to $2.3 million in 2024, then surged by 154.7% to $5.9 million in 2025, then tumbled by 31.32% to $4.0 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $4.0 million, $7.3 million, and $5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 51.76 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 18.30 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 50.85 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 23.99 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 25.17 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 10.72 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 21.60 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 2.62 Bn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 7.22 Bn
10 Femasys 9.01 Mn 7.57 Mn 189,391.00 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.03 Mn
Mar 31, 2026 7.29 Mn
Dec 31, 2025 5.87 Mn
Sep 30, 2025 4.56 Mn
Jun 30, 2025 1.51 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 5.97 Mn
Jun 30, 2024 11.25 Mn
Mar 31, 2024 15.61 Mn
Dec 31, 2023 18.35 Mn
Sep 30, 2023 10.44 Mn
Jun 30, 2023 12.88 Mn
Mar 31, 2023 12.36 Mn
Dec 31, 2022 15.24 Mn
Sep 30, 2022 18.01 Mn
Jun 30, 2022 20.94 Mn
Mar 31, 2022 23.49 Mn
Dec 31, 2021 26.33 Mn
Sep 30, 2021 28.65 Mn